KJHP
RMD icon

K.J. Harrison & Partners’s ResMed RMD Stock Holding History

K.J. Harrison & Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$585K Buy
+3,000
New +$622K 0.08% 163

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

K.J. Harrison & Partners's RMD Position: Q2 2026 in Review

K.J. Harrison & Partners opened a new position in ResMed (RMD) in Q2 2026: 3,000 shares worth $585K. The stake represents 0.08% of the portfolio and ranks #163 among its holdings.

882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • K.J. Harrison & Partners held 3,000 shares of ResMed worth $585K as of Q2 2026.
  • ResMed was a new K.J. Harrison & Partners position in Q2 2026.
  • ResMed made up 0.08% of K.J. Harrison & Partners's portfolio in Q2 2026, its #163 holding.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on K.J. Harrison & Partners's 13F filing for Q2 2026, filed 7 Aug 2026.